Jean-Daniel Abraham

Jean-Daniel Abraham is responsible for R&D at Regentis-Pharma. Engineer in biotechnology and doctor in virology, he worked on gene therapy or vaccine projects based on recombinant viral vectors (adenovirus, poxvirus), then developed his career in the in vitro diagnosis of complex pathologies (Alzheimer’s disease, autoimmune diseases, cancer, psychiatric disorders) or infectious diseases (Zika, Dengue, Chikungunya). During this work, Jean-Daniel has acquired extensive experience in the management of clinical projects in order to validate the biomarkers discovered and the associated in vitro tests, relying on R&D teams whether industrial, academic or hospital.